ABVC BioPharma Inc (ABVC)
1.04
+0.05
(+5.04%)
USD |
NASDAQ |
Apr 22, 16:00
1.03
-0.01
(-0.96%)
Pre-Market: 09:21
ABVC BioPharma Debt to Equity Ratio: 0.1751 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1751 |
| September 30, 2023 | 0.2754 |
| June 30, 2023 | -11.03 |
| March 31, 2023 | 2.460 |
| December 31, 2022 | 0.6112 |
| September 30, 2022 | 0.3153 |
| June 30, 2022 | 0.1686 |
| March 31, 2022 | 0.2412 |
| December 31, 2021 | 0.1854 |
| September 30, 2021 | 0.2243 |
| June 30, 2021 | 3.178 |
| March 31, 2021 | 1.772 |
| December 31, 2020 | 1.370 |
| September 30, 2020 | -4.754 |
| June 30, 2020 | -3.786 |
| March 31, 2020 | -3.625 |
| December 31, 2019 | -26.76 |
| September 30, 2019 | 5.650 |
| June 30, 2019 | -0.9419 |
| March 31, 2019 | -0.5615 |
| December 31, 2018 | -0.1391 |
| September 30, 2018 | -0.2246 |
| June 30, 2018 | -0.2458 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 1.342 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.2337 |
| March 31, 2015 | 0.244 |
| December 31, 2014 | 0.237 |
| September 30, 2014 | 0.2232 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.6787 |
| June 30, 2012 | -0.7036 |
| March 31, 2012 | -0.6202 |
| December 31, 2011 | -0.8107 |
| September 30, 2011 | -0.7859 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-26.76
Minimum
Dec 2019
5.650
Maximum
Sep 2019
-1.803
Average
0.2243
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| NeuBase Therapeutics Inc | -- |
| Sutro Biopharma Inc | 0.0271 |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | 0.3015 |
| Journey Medical Corp | 0.7185 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.49M |
| Total Liabilities (Quarterly) | 6.362M |
| Shareholders Equity (Quarterly) | 8.388M |
| Current Ratio | 0.2793 |
| Net Debt Paydown Yield | 0.87% |